Unlocking the Mystery of Digenic Deafness: GJB2/GJB3

Deafness, digenic, GJB2/GJB3

Expert Reviewed By: Dr. Brandon Colby MD

Understanding Digenic Deafness

Digenic Deafness, specifically caused by mutations in the GJB2 and GJB3 genes, is a type of hereditary hearing loss that results from a combination of genetic factors. Unlike other forms of genetic deafness, digenic deafness involves the interaction of two different genes, each carrying a mutation, which together lead to hearing impairment. This type of inheritance is relatively rare and can make the diagnosis of digenic deafness more complex than other forms of hereditary hearing loss.

Diagnosing Digenic Deafness

Diagnosing digenic deafness can be challenging due to the involvement of multiple genes. However, recent advancements in genetic testing have made it possible to identify the specific mutations responsible for this type of hearing loss. A study on digenic inheritance of deafness caused by mutations in cadherin 23 and protocadherin 15 found that these mutations can interact to cause hearing loss in both mice and humans. Another study on large deletion in GJB6 in recessive non-syndromic deafness showed that homozygous deletion of a 150 kb region encompassing the GJB6 gene causes non-syndromic hearing loss. These studies highlight the importance of genetic testing in diagnosing digenic deafness.

Genetic Testing for Digenic Deafness

Genetic testing for digenic deafness involves analyzing the DNA of an individual to identify the specific mutations in the GJB2 and GJB3 genes that are responsible for their hearing loss. This can be done through various methods, including clinical exome sequencing, which was used in a study to diagnose Alport Syndrome and Thin Basement Membrane Disease in 95 patients, identifying causative variants in 45.3% of them.

Benefits of Genetic Testing for Digenic Deafness

There are several benefits to using genetic testing for the diagnosis of digenic deafness, including:

  • Accurate diagnosis: Genetic testing can help accurately identify the specific gene mutations responsible for an individual's hearing loss, providing a definitive diagnosis.
  • Early intervention: Early diagnosis of digenic deafness allows for appropriate intervention strategies to be implemented, such as hearing aids, cochlear implants, or other assistive devices, which can improve the quality of life for affected individuals.
  • Family planning: Genetic testing can provide valuable information for couples who may be carriers of the GJB2 and GJB3 gene mutations, allowing them to make informed decisions about family planning and the potential risk of passing on the genetic mutations to their children.
  • Research: Identifying the specific gene mutations responsible for digenic deafness can help researchers better understand the underlying genetic mechanisms and potentially develop targeted treatments or therapies in the future.

Considerations for Genetic Testing

While genetic testing for digenic deafness can provide valuable information, there are some important considerations to keep in mind:

  • Cost: Genetic testing can be expensive, and not all insurance plans may cover the cost of testing for digenic deafness.
  • Emotional impact: Receiving a definitive diagnosis of digenic deafness can be emotionally challenging for individuals and their families, as they may need to adjust to the reality of living with a genetic hearing loss.
  • Genetic counseling: It is important for individuals considering genetic testing for digenic deafness to receive appropriate genetic counseling, both before and after testing, to ensure they fully understand the implications of their test results and can make informed decisions about their healthcare and family planning.

In conclusion, genetic testing for digenic deafness can provide valuable information for the diagnosis, early intervention, and family planning of individuals affected by this rare form of hereditary hearing loss. With appropriate genetic counseling and support, individuals and their families can better understand the implications of their test results and make informed decisions about their healthcare and future.

About The Expert Reviewer

Dr. Brandon Colby MD is a US physician specializing in the personalized prevention of disease through the use of genomic technologies. He’s an expert in genetic testing, genetic analysis, and precision medicine. Dr. Colby is also the Founder of  and the author of ⁠Outsmart Your Genes.

Dr. Colby holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University’s Graduate School of Business, and a degree in Genetics with Honors from the University of Michigan. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (⁠ACMG), an Associate of the American College of Preventive Medicine (⁠ACPM), and a member of the National Society of Genetic Counselors (NSGC)